HAP Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.2K | Sell |
33,700
-165,300
| -83% | -$4.08M | ﹤0.01% | 722 |
|
|
2025
Q2 | $127K | Sell |
199,000
-66,900
| -25% | -$1.56M | 0.01% | 393 |
|
|
2025
Q1 | $366K | Buy |
265,900
+37,800
| +17% | +$989K | 0.04% | 226 |
|
|
2024
Q4 | $285K | Buy |
228,100
+158,800
| +229% | +$4.31M | 0.02% | 261 |
|
|
2024
Q3 | $101K | Buy |
69,300
+400
| +0.6% | +$11.7K | 0.01% | 398 |
|
|
2024
Q2 | $82.6K | Buy |
68,900
+17,200
| +33% | +$474K | 0.01% | 391 |
|
|
2024
Q1 | $64.1K | Sell |
51,700
-12,500
| -19% | -$347K | 0.01% | 401 |
|
|
2023
Q4 | $82.8K | Buy |
64,200
+12,100
| +23% | +$366K | 0.01% | 389 |
|
|
2023
Q3 | $95.8K | Buy |
52,100
+500
| +1% | +$17.7K | 0.02% | 393 |
|
|
2023
Q2 | $117K | Sell |
51,600
-27,200
| -35% | -$1.06M | 0.02% | 363 |
|
|
2023
Q1 | $313K | Sell |
78,800
-5,800
| -7% | -$251K | 0.05% | 242 |
|
|
2022
Q4 | $213K | Sell |
84,600
-94,400
| -53% | -$4.53M | 0.02% | 455 |
|
|
2022
Q3 | $717K | Buy |
179,000
+59,100
| +49% | +$2.87M | 0.05% | 303 |
|
|
2022
Q2 | $368K | Sell |
119,900
-63,000
| -34% | -$3.21M | 0.02% | 518 |
|
|
2022
Q1 | $445K | Sell |
182,900
-96,800
| -35% | -$5.02M | 0.02% | 568 |
|
|
2021
Q4 | $122K | Buy |
279,700
+36,600
| +15% | +$1.81M | ﹤0.01% | 1174 |
|
|
2021
Q3 | $344K | Sell |
243,100
-58,300
| -19% | -$2.58M | 0.01% | 812 |
|
|
2021
Q2 | $369K | Buy |
301,400
+38,900
| +15% | +$1.51M | 0.01% | 753 |
|
|
2021
Q1 | $467K | Buy |
262,500
+39,100
| +18% | +$1.39M | 0.03% | 506 |
|
|
2020
Q4 | $299K | Buy |
223,400
+111,149
| +99% | +$4.08M | 0.01% | 815 |
|
|
2020
Q3 | $149K | Buy |
112,251
+63,345
| +130% | +$2.22M | 0.01% | 710 |
|
|
2020
Q2 | $196K | Buy |
48,906
+2,635
| +6% | +$89.5K | 0.01% | 690 |
|
|
2020
Q1 | $225K | Sell |
46,271
-288,796
| -86% | -$9.84M | 0.02% | 520 |
|
|
2019
Q4 | $263K | Buy |
335,067
+287,742
| +608% | +$10.2M | 0.01% | 418 |
|
|
2019
Q3 | $103K | Buy |
47,325
+20,553
| +77% | +$747K | 0.01% | 609 |
|
|
2019
Q2 | $33K | Sell |
26,772
-2,845
| -10% | -$113K | ﹤0.01% | 806 |
|
|
2019
Q1 | $48K | Buy |
+29,617
| New | +$1.19M | ﹤0.01% | 681 |
|
|
2018
Q3 | – | Sell |
-29,723
| Closed | -$21K | – | 1126 |
|
|
2018
Q2 | $21K | Buy |
29,723
+8,011
| +37% | +$274K | ﹤0.01% | 801 |
|
|
2018
Q1 | $21K | Sell |
21,712
-8,959
| -29% | -$308K | ﹤0.01% | 761 |
|
|
2017
Q4 | $8K | Buy |
30,671
+9,802
| +47% | +$334K | ﹤0.01% | 879 |
|
|
2017
Q3 | $11K | Buy |
20,869
+5,586
| +37% | +$180K | ﹤0.01% | 796 |
|
|
2017
Q2 | $19K | Sell |
15,283
-2,424
| -14% | -$76.4K | ﹤0.01% | 795 |
|
|
2017
Q1 | $20K | Sell |
17,707
-549,556
| -97% | -$17.3M | ﹤0.01% | 835 |
|
|
2016
Q4 | $60K | Buy |
567,263
+2,635
| +0.5% | +$80.4K | ﹤0.01% | 626 |
|
|
2016
Q3 | $189K | Buy |
564,628
+527
| +0.1% | +$17.6K | 0.01% | 513 |
|
|
2016
Q2 | $299K | Sell |
564,101
-958,824
| -63% | -$30.6M | 0.02% | 383 |
|
|
2016
Q1 | $1.35M | Sell |
1,522,925
-1,002,881
| -40% | -$28.6M | 0.1% | 172 |
|
|
2015
Q4 | $1.3M | Buy |
2,525,806
+2,410,709
| +2,095% | +$75.8M | 0.06% | 237 |
|
|
2015
Q3 | $82K | Buy |
115,097
+65,137
| +130% | +$2.09M | ﹤0.01% | 636 |
|
|
2015
Q2 | $15K | Buy |
49,960
+14,124
| +39% | +$460K | ﹤0.01% | 810 |
|
|
2015
Q1 | $6K | Sell |
35,836
-58,392
| -62% | -$1.86M | ﹤0.01% | 830 |
|
|
2014
Q4 | $51K | Buy |
94,228
+62,819
| +200% | +$1.8M | ﹤0.01% | 728 |
|
|
2014
Q3 | $16K | Buy |
+31,409
| New | +$882K | ﹤0.01% | 869 |
|
|
2014
Q1 | – | Sell |
-396,936
| Closed | -$2K | – | 1305 |
|
|
2013
Q4 | $2K | Buy |
+396,936
| New | +$11.6M | ﹤0.01% | 1134 |
|
|
2013
Q3 | – | Sell |
-8,964,270
| Closed | -$53.9M | – | 861 |
|
|
2013
Q2 | $53.9M | Buy |
+8,964,270
| New | +$248M | 1.82% | 10 |
|
Other funds holding PFE
HAP Trading's PFE Position: Q3 2025 in Review
HAP Trading sold out of Pfizer (PFE) in Q3 2025, closing a stake of 61,326 shares — an estimated $1.51M sold.
HAP Trading first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $182M in Q2 2013. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- HAP Trading reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 61,326 Pfizer shares in Q3 2025, an estimated $1.51M.
- HAP Trading first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
- HAP Trading's Pfizer position peaked at $182M in Q2 2013.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.